Ajinomoto

Last updated January 31, 2026

Innovation Areas

1,635

Inventors

Collaborations

Bioactive metabolic pathway modulators: AjinomotoRecent Research Landscape

Cancer-related fatigue creates severe patient non-compliance and treatment discontinuation risks, which these compounds mitigate by modulating neuro-inflammatory and metabolic signaling pathways. Controlling these specific biochemical triggers allows for sustained high-dose oncology regimens without debilitating physical exhaustion.

What technical problems is Ajinomoto addressing in Bioactive metabolic pathway modulators?

Physiological functional decline

(5)evidences

Spontaneous non-enzymatic bonding of sugars to proteins leads to structural degradation and systemic metabolic dysfunction. Preventing this damage mitigates chronic complications like iron deficiency and tissue aging.

Cognitive and neurological decline

(3)evidences

Pathological loss of cognitive capacity and structural brain volume. Mitigating these deficits prevents irreversible functional impairment and psychological distress.

Chemotherapy induced muscle degradation

(2)evidences

Systemic energy depletion and pathological exhaustion in oncology patients. Addressing this failure mode restores functional capacity and patient quality of life.